OHSU Knight Cancer Institute Director receives prestigious Stanley J. Korsmeyer Award
February 16, 2011
Brian J. Druker, M.D. — whose research led to the development of Gleevec, the first genetically targeted cancer drug that left healthy cells unharmed and revolutionized how the disease is treated — has received the prestigious Stanley J. Korsmeyer ...